Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus
Open Access
- 1 October 2011
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 19 (10), 1858-1866
- https://doi.org/10.1038/mt.2011.144
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSFMolecular Therapy, 2010
- A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus SensitizersMolecular Therapy, 2010
- Impact of tumor microenvironment on oncolytic viral therapyCytokine & Growth Factor Reviews, 2010
- Progress and prospects: immune responses to viral vectorsGene Therapy, 2009
- In situ adenovirus vaccination engages T effector cells against cancerVaccine, 2009
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008
- A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal AdenomasGastroenterology, 2006
- Celecoxib for the Prevention of Colorectal Adenomatous PolypsNew England Journal of Medicine, 2006
- Celecoxib for the Prevention of Sporadic Colorectal AdenomasNew England Journal of Medicine, 2006
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003